I've held for some time - when there was only one asset (CHM 1101 CLTX CAR T) - and there was good news flow on the progress of the first trial, escalating dosages ICT and ICV for GBM. I'm not sure if I've missed it but I can't recall any updates for a long time and, as far as I am aware, there were a number of further escalations to run. The presentation is not clear on this. It's great we have seven assets to progress but where are we on the first? Appreciate it if anyone is aware and can update.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.5¢ | 0.4¢ | $11.72K | 2.783M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 2757364 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 15260220 | 25 |
View Market Depth
| Last trade - 16.10pm 23/06/2025 (20 minute delay) ? |
| CHM (ASX) Chart |